Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Open in API
Filings indexed 1,765 across all filing types
Latest filing 2023-04-24 Capital/Financing Update
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Capital/Financing Update Classification · 100% confidence The document is a short letter dated 24th April 2023 addressed to stock exchanges (BSE and NSE) informing about the redemption and repayment of a portion of the company's Non-Convertible Debentures (NCDs). It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities). The document length is only 1337 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Capital/Financing Update (CAP).
2023-04-24 English
Redemption
Capital/Financing Update Classification · 95% confidence The document is a short letter dated 24th April 2023 addressed to stock exchanges (BSE and NSE) informing about the redemption and repayment of Non-Convertible Debentures (NCDs) by the company. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities). The document length is only 1337 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Capital/Financing Update (CAP) rather than a full financial report or regulatory filing.
2023-04-24 English
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Secured Redeemable Non-Convertible Debentures ....
Capital/Financing Update Classification · 95% confidence The document is a short official letter dated 21 April 2023 from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE). It announces the full redemption and repayment of Secured Redeemable Non-Convertible Debentures (NCDs) worth 200 crores. The document references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities). The document length is only 1256 characters, indicating it is a brief announcement rather than a detailed report. Therefore, it fits the category of Capital/Financing Update (CAP) rather than a full financial report or regulatory filing.
2023-04-21 English
Redemption
Capital/Financing Update Classification · 95% confidence The document is a short notification letter dated 21 April 2023 from Torrent Pharmaceuticals Limited addressed to stock exchanges (BSE and NSE). It informs about the full redemption and repayment of Secured Redeemable Non-Convertible Debentures (NCDs) worth 200 crores. The document references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, specifically Regulation 30, which pertains to disclosure of material events. The content is an update on a financing activity (redemption of debt securities), not a full financial report or audit. The document length is only 1256 characters, indicating it is a brief announcement rather than a detailed report. Therefore, the appropriate classification is Capital/Financing Update (CAP).
2023-04-21 English
With reference to the above, we enclose herewith copy of the Compliance Certificate under Regulation 40(9) of SEBI (LODR) Regulations, 2015 issued by RPAP & Co., Practicing Company Secretaries, ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate issued under Regulation 40(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31st March 2023. It is a certificate from a practicing company secretary regarding the transfer of securities and related compliance, not a full financial report or audit report. The document length is short (3051 characters) and it is a certification letter rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and not an annual report, audit report, or other specific filing type.
2023-04-14 English
In compliance with the requirements under 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed herewith Compliance Certificate for ....
Regulatory Filings Classification · 95% confidence The document is a Compliance Certificate submitted under Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the year ended 31st March 2023. It is issued by KFIN Technologies Limited certifying their role as Registrar and Share Transfer Agent for Torrent Pharmaceuticals Limited. The document is a formal certification letter, not a financial report or detailed filing. It is short (3170 characters) and serves as a regulatory compliance submission rather than a report containing financial data or management discussion. Therefore, it fits best under Regulatory Filings (RNS) as it is a compliance certificate and not a full report or announcement of a report.
2023-04-10 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.